When was Ocean Genomics founded?

Ocean Genomics was founded in 2018 and raised its 1st funding round 5 years after it was founded.

Where is Ocean Genomics located?

Ocean Genomics is headquartered in Pittsburgh, United States.

Who is the current CEO of Ocean Genomics?

Carl Kingsford of Ocean Genomics. They have also founded 1 company.

How many employees does Ocean Genomics have?

As of Mar 31, 2026, the latest employee count at Ocean Genomics is 10.

Is Ocean Genomics a funded company?

Ocean Genomics is a funded company, having raised a total of $***** in its 1st and only funding round, a Seed round on Feb 16, 2023.

When was the latest funding round of Ocean Genomics?

Ocean Genomics' latest funding was a $***** Seed round on Feb 16, 2023, with participation from 1 investor. Its primary sector is Genomics. In United States, the Genomics sector has seen $2.31B in funding in 2026 to date.

Where does Ocean Genomics rank among its competitors?

Ocean Genomics ranks 195th amongst 573 active competitors, of which 90 are funded. It stands 11th in terms of total funding among its competitors. The most recent competitor to raise funding was Transcripta Bio, which secured $24M in Jul, 2026.

Who are the top competitors of Ocean Genomics?

Ocean Genomics' top competitors include Benchling, Helix and Formation Bio. Among them, Transcripta Bio secured the most recent funding round in July, 2026.

Ocean Genomics - 2026 Company Profile, Team, Funding & Competitors

Company Details

Developer of a transcriptome analysis platform using AI. The company's technology platform is used to measure the expression level of transcriptomics. It is also used for the identification of biomarkers for drug development, finding drug targets, new isoforms, and splicing errors.

Website: oceangenomics.com
Social
Email ID: *****@oceangenomics.com

Key Metrics

Founded Year

2018

Location

Pittsburgh, United States

Stage

Seed

Latest Funding Round

Seed, Feb 16, 2023, $*****

Investors

Accenture

Ranked

195^th among 573 active competitors

Employee Count

10 as on Mar 31, 2026

Similar Companies

Benchling & 732 more

View Ocean Genomics' full profile

Ocean Genomics has raised funding over 1 round. Its latest funding round was a Seed round on Feb 16, 2023 for $*****. 1 investor participated in its latest round. Ocean Genomics has 1 institutional investor.

Here is the list of recent funding rounds of Ocean Genomics:

Date of Funding	Funding Amount	Round Name	Post-Money Valuation	Revenue Multiple	Lead Investors	Other Investors
Feb 16, 2023	1721977	Seed	9048525	7984106	4718480	8622263

Access funding benchmarks and valuations. Sign up today!

View details of Ocean Genomics's funding rounds and investors

The founders of Ocean Genomics are Robert Patro and Carl Kingsford. Carl Kingsford is the CEO of Ocean Genomics.

Here are the details of Ocean Genomics' key team members:

Robert Patro: Co-Founder of Ocean Genomics.
Contact Info: 1 email address
Carl Kingsford: Co-Founder & CEO of Ocean Genomics.
Contact Info: 1 email address

View details of Ocean Genomics's Founder profiles and Board Members

Ocean Genomics' employee count trend

Ocean Genomics has 10 employees as of Mar 26. Here is Ocean Genomics's employee count trend over the years:

Uncover Ocean Genomics' growth story! Sign up today!

Access Tracxn on any website

Our Google Chrome extension lets you view company details while browsing their websites

Install Tracxn Extension

Top competitors of Ocean Genomics include Benchling, Helix and Formation Bio. Here is the list of Top 10 competitors of Ocean Genomics, ranked by Tracxn score:

Rank	Company Details	Short Description	Total Funding	Investors	Tracxn Score
1st	Benchling 2012, San Francisco (United States), Series F	Provider of a cloud-based bioinformatics platform for biotech research	$412M	Altimeter Capital, Benchmark & 29 others	73/100
2nd	Helix 2015, San Francisco (United States), Series E	Provider of a genomic database for clinical research	$435M	DFJ Growth, Kleiner Perkins & 12 others	71/100
3rd	Formation Bio 2016, New York City (United States), Series D	Provider of AI-powered drug discovery platform for various diseases	$608M	Andreessen Horowitz, Sequoia Capital & 17 others	70/100
4th	Sophia Genetics 2011, Rolle (Switzerland), Public	Provider of artificial intelligence software for analyzing complex medical data	$249M	Generation Investment Management, Endeavour Vision ... & 24 others	62/100
5th	Cellarity 2015, Cambridge (United States), Series C	AI-powered drug design and development platform	$294M	Pictet Group, The Baupost Group & 6 others	61/100
6th	Transcripta Bio 2020, Palo Alto (United States), Series B	AI-powered platform for drug screening and development	$34M	Omnimed Capital, Mayo Clinic Ventures & 2 others	59/100
7th	Latch 2021, San Francisco (United States), Series A	Provider of a web-based platform for genomic bioinformatics	$33M	Lux Capital, Coatue & 7 others	59/100
8th	BostonGene 2015, Waltham (United States), Series B	Developer of cloud-based information and analytics platform to treat cancer	$200M	NEC, Japan Industrial Partners & 1 others	57/100
9th	Arpeggio 2017, Boulder (United States), Series B	Provider of drug discovery platform for the treatment of cancer	$49.5M	Y Combinator, FundersClub & 15 others	55/100
10th	54gene 2019, Lagos (Nigeria), Deadpooled	Provider of gene biobanking database and services for research purposes	$45M	Better Ventures, Fifty Years & 20 others	54/100
195th	Ocean Genomics 2018, Pittsburgh (United States), Seed	Developer of a transcriptome analysis platform using AI	-	Accenture	26/100